Table 3 Chromosome loci and OMIM disease annotation of microRNA
From: Screening of differentially expressed microRNAs of essential hypertension in Uyghur population
MicroRNA | Chr_location | Number of target genes | MIM Number | MIM Title |
|---|---|---|---|---|
hsa-miR-1182 | 1q42.2 | 145 | #145500/ + 106,150 | HYPERTENSION, ESSENTIAL/ ANGIOTENSINOGEN; AGT |
hsa-miR-30e-5p | 1p34.2 | 73 | – | – |
hsa-miR-557 | 1q24.2 | 306 | *131210/ *182330/ #145500 | SELECTIN E; SELE/ ATPase, Na+/K+ TRANSPORTING, BETA-1 POLYPEPTIDE; ATP1B1/ HYPERTENSION, ESSENTIAL |
hsa-miR-765 | 1q23.1 | 475 | – | – |
hsa-miR-92b-3p | 1q22 | 131 | #151660 | LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 2; FPLD2 |
hsa-miR-149-5p | 2q37.3 | 153 | – | – |
hsa-miR-933 | 2q31.1 | 11 | – | – |
hsa-miR-1224-3p/5p | 3q27.1 | 260 | – | – |
hsa-miR-198 | 3q13.33 | 169 | – | – |
hsa-miR-564 | 3p21.31 | 53 | *160790 | MYOSIN, LIGHT CHAIN 3, ALKALI, VENTRICULAR, SKELETAL, SLOW; MYL3 |
hsa-miR-574-5p | 4 | 179 | – | – |
hsa-miR-575 | 4q21.22 | 105 | – | – |
hsa-miR-378a-3p | 5q32 | 86 | – | – |
hsa-miR-874-3p | 5q31.2 | 142 | #614495/ *605775 | PSEUDOHYPOALDOSTERONISM, TYPE IID; PHA2D/ KELCH-LIKE 3; KLHL3 |
hsa-miR-877-5p | 6p21.33 | 170 | – | – |
hsa-miR-1183 | 7 | 347 | – | – |
hsa-miR-1234-3p | 8 | 16 | – | – |
hsa-miR-30d-5p | 8q24.22 | 69 | – | – |
hsa-miR-939-5p | 8q24.3 | 305 | #103900/ *608216 | GLUCOCORTICOID-REMEDIABLE ALDOSTERONISM; GRA/ COMM DOMAIN-CONTAINING PROTEIN 5; COMMD5 |
hsa-miR-601 | 9q33.3 | 70 | – | – |
hsa-miR-936 | 10q25.1 | 221 | *601568 | ADDUCIN 3; ADD3 |
hsa-miR-1237-3p | 11 | 129 | – | – |
hsa-miR-129-2-3p | 11p11.2 | 26 | #125853 | DIABETES MELLITUS, NONINSULIN-DEPENDENT; NIDDM |
hsa-miR-483-3p | 11p15.5 | 34 | #125852/ *191290 | DIABETES MELLITUS, INSULIN-DEPENDENT, 2/ TYROSINE HYDROXYLASE; TH |
hsa-miR-623 | 13q32.3 | 231 | – | – |
hsa-miR-1260a | 14 | 134 | – | – |
hsa-miR-494-3p | 14q32.31 | 89 | – | – |
hsa-miR-484 | 16p13.11 | 133 | *603234/ #264800 | ATP-BINDING CASSETTE, SUBFAMILY C, MEMBER 6; ABCC6/ PSEUDOXANTHOMA ELASTICUM; PXE |
hsa-miR-940 | 16p13.3 | 393 | #173900/ *610886/ *601313 | POLYCYSTIC KIDNEY DISEASE 1; PKD1/ ESSENTIAL MEIOTIC ENDONUCLEASE 1, S. POMBE, HOMOLOG OF, 2; EME2/ POLYCYSTIN 1; PKD1 |
hsa-miR-144-3p | 17q11.2 | 43 | *163730/ #162200/ #145500 | NITRIC OXIDE SYNTHASE 2A; NOS2A/ NEUROFIBROMATOSIS, TYPE I; NF1/ HYPERTENSION, ESSENTIAL |
hsa-miR-22-3p | 17p13.3 | 97 | – | – |
hsa-miR-636 | 17q25.1 | 163 | – | – |
hsa-miR-1238-3p | 19 | 51 | – | – |
hsa-miR-1323 | 19q13.42 | 157 | – | – |
hsa-miR-371a-5p | 19q13.42 | 183 | – | – |
hsa-miR-498 | 19q13.42 | 188 | – | – |
hsa-miR-516a-5p | 19q13.42 | 12 | – | – |
hsa-miR-526b-5p | 19q13.42 | 115 | – | – |
hsa-miR-769-3p | 19q13.32 | 122 | + 107,741 | APOLIPOPROTEIN E; APOE |
hsa-miR-1825 | 20 | 40 | – | – |
hsa-miR-1281 | 22 | 12 | – | – |
hsa-miR-659-3p | 22q13.1 | 284 | – | – |
hsa-miR-92a-3p | 13q31.3/Xq26.2 | 165 | – | – |
hsa-miR-223-3p | Xq12 | 62 | – | – |
hsa-miR-361-5p | Xq21.2 | 92 | – | – |
hsa-miR-766-3p | Xq24 | 139 | – | – |